Tag:
ProStrakan
Latest Headlines
Latest Headlines
Kyowa acquiring ProStrakan for £300M
Japan's Kyowa Hakko Kirin has snagged Scotland's ProStrakan in a £300 million deal. "As one of our licensees, KHK is a known quantity and the rationale behind the deal is for KHK to use
Endo gets green light for new testosterone gel
The FDA is giving a green light to a new testosterone gel developed by Endo Pharmaceuticals ( $ENDP ) and ProStrakan. Shares of Endo were buoyed by the news, Reuters notes. Fortesta was studied as a
Aveva plant restart rekindles BioDelivery, ProStrakan
Products from two drugmakers are going back into production following the facility restart of contract manufacturer Aveva Drug Delivery Systems. Aveva has notified the FDA that it plans to resume
Endo inks $210M deal for testosterone therapy
Endo Pharmaceuticals has handed out a $10 million upfront payment for the U.S. licensing rights to ProStrakan's testosterone replacement therapy Fortesta. The UK's ProStrakan also stands to gain $200
